MENG Yan-qiu, LIU Li-wei, LIU Dong-ying, SONG Yan-ling. Advances in study of Survivin inhibitorsJ. Acta Pharmaceutica Sinica, 2016,51(3): 347-355. doi: 10.16438/j.0513-4870.2015-0579
Citation: MENG Yan-qiu, LIU Li-wei, LIU Dong-ying, SONG Yan-ling. Advances in study of Survivin inhibitorsJ. Acta Pharmaceutica Sinica, 2016,51(3): 347-355. doi: 10.16438/j.0513-4870.2015-0579

Advances in study of Survivin inhibitors

  • Survivin, a member of the inhibitor of apoptosis proteins family, is considered to be an important target of anticancer treatment for its key role in the control of cell division and cell apoptosis. Currently, only a few Survivin inhibitors have been developed, and most of them reduce Survivin level by interacting with other biomolecules instead of directly interacting with Survivin protein. This review summarizes the structure of Survivin protein, the mechanism of action and research progress of Survivin inhibitors, which may has a great significance in the study of selective Survivin inhibitors in the future.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return